Navigation Links
Synteract Expands Executive Roles to Support Growth
Date:3/5/2012

SAN DIEGO, March 5, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), has hired Matthew P. Smith, MBA, as senior vice president of sales and marketing and has promoted Rod M. Saponjic, Ph.D., MBA, to senior vice president, global project management, to support growth in the company and development of international opportunities. Both executives join CEO Wendel Barr, COO Stewart Bieler, and CFO Patrik Jeanmonod on the executive council for the company.

(Logo:  http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Matt Smith has overall responsibility for global sales operations, business development, marketing, proposals and contracting at Synteract.  He has more than 20 years experience in executive leadership, clinical trial management, business development, proposal development and contracts administration within the contract research industry.  Prior to Synteract, Smith was CEO and chief business officer of Clinimetrics, a full-service public contract research organization also focused on the development needs of biopharmaceutical and medical device companies.  Previously, he held roles of increasing responsibility at Quintiles in the areas of Phase I-IV clinical trial operations, project management, and business development.  Matt brings to Synteract a passion for developing high quality partnerships through strong client communication and solid internal business management and structure. 

As senior vice president of global project management, Dr. Rod Saponjic is responsible for harmonizing project management methodologies, training and operations across the organization. He also provides guidance and support for project teams focused on achieving deliverables for clients. Saponjic has been with Synteract for more than two years, having joined the company after five years with PRA International, where he held a similar role. Saponjic is widely recognized for his industry knowledge, business acumen, executive leadership and influence on the standardization and quality development of project management.

"Our vision is to become the leading global CRO focused on emerging companies. By hiring Matt, promoting Rod, and adding to our sales teams we are making significant steps in that direction," says Synteract CEO Wendel Barr. "In addition we are planning to increase our investment in Information Technology to leverage technology to drive client satisfaction, business productivity, and enhance our services. It is an exciting time to be working at Synteract."  

The company also has opened a search for a manager to head sales operations, reporting directly to Matt Smith and responsible for proposals, contracts, deployment of a new sales support system (CRM), and measuring the effectiveness of sales efforts.  In addition, there are openings in its East coast office in Data Management, Biostatistics, Safety, and Project Management.  Interested applicants can contact Micaela Meeks at mmeeks@synteract.com .

About Synteract (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
2. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
3. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
4. HRID Expands Distribution of Azul Instant™ Into Puerto Rico
5. Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc.
6. Bayer Expands Its Hemophilia Leadership Development Program
7. AMPAC Fine Chemicals Expands Into Controlled Substance Manufacturing
8. Sanovas Expands Headquarters and Opens Manufacturing Site
9. PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
10. CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
11. Myoderm Expands International Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... to 2023" report to their offering. ... The ablation device global market is ... million by 2023. Ablation is the minimally invasive ... from cancerous or diseased tissue removal, to the removal of abnormally ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... ... 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. ... patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... experience. When patients receive early treatment, they may achieve straight teeth with less treatment ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Curio Wellness ... to announce the finalization of the company’s executive management team with prominent executives from ... operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... Philadelphia, PA (PRWEB) , ... March 29, 2017 , ... ... Moelis, W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift ... a deferred admission opportunity that will provide a pathway to a Wharton MBA for ...
Breaking Medicine News(10 mins):